Dr. Hubert Ridolphi

At VCLS, I have the opportunity to lead our business development in Switzerland and key account management efforts across Europe. Strategic Partnership Development: to enhance our service offerings. Go-to-Market Strategy: Conceptualized and executed local go-to-market strategies. Team Leadership: Directed (CH) and mentored a team of 6+ Business Development Associates and Managers across Europe.

Project Manager and/or Lead Senior Consultant to deliver business related IT projects or advisory assignments Heath Data compliance and Data governance “Envision” advisory to the Life Science Industry Pre-Sales multichannel activities pertaining to our operational strategy Build success-based alliance partnerships with key Health related software vendors, relationship & alliance management Proposal Manager to generate commercially sustainable offers in line with our Health Business Line strategy

GBA Pharma provides tailored services to meet your demands during your drug development processes. • Pre-clinical CRO services [Bioanalysis, in vivo/vitro studies…] • cGMP analytical services [R&D, Methods dev. & validation, Extractable and Leachable…] o Central Laboratory services [more than 1500 worldwide clinical trials supported since 1991] o Clinical Trial supply management [Sourcing, Storage in GMP Depots worldwide, QP release, GDP Logistics…]

Reporting on Oncology Biosimilar mAb & ADC Markets & Trends [2018-2024] including manufacturing, analytical, CMC, regulatory and IP aspects

Sales Management of a start-up organization providing solutions to the life science industries and partners with an E-Health data middleware devoted to personal data management. [HIPAA-GDPR-13485 SaMD]. Sales Lead Generation and Nurturing Strategies: defining actions needed to ensure long-term success, getting known and recognized amongst eHealth Industries (Medical IoT) and ehealth regulation leaders.

Startup CDMO, focusing on Aseptic GMP Fill & Finish services manufacturing clinical trials and small scale commercial batches

Developing a qualified pipeline of +$500M for a new line of business (Biosimilar 2nd generation) for a leading Pharmerging market company by writing accurate reports through the detailed analysis of Worldwide data: Revamping Corporate Strategy of a CMO: a throughout review of a Dose CMO (aseptic biologic filling) Corporate Strategy: • Pitch, KPIs, Industry and Competitive Analysis, Customer and products targeting strategy and tactics.

pixon is a leading Swiss Biopharma Engineering Company with +10 years’ experience in the field of engineering and design provider of manufacturing facilities and processes. Project Leader for a spin-off startup CMO, all Business Plan and future Manufacturing Operations Aspects with the result of the company creation.

Swiss biotechnology and pharmaceutical company acquired by Galenica in 2009 (CHF 240 M Turnover) : Marketing and Sales Manager Eastern and Central Europe. Direct all aspects of CHF Multimillion Marketing & Sales operations *Orchestrated to raise the long life cycle products turnover first by 8% then 26% in 2003 *Created new partnerships and motivated people (managed 7 country managers, 2 licensees and 43+ indirect MedReps reports)

* Project Manager : Successfully conducted the launch of a new wound dressing products range. ** Manage the marketing and sales activities of the company’s representation offices in EEC and Central Asia Markets *** Increased Sales Performance by 20 % annually in this area

Strategy and Market Access

Marketing and Sales